Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food-effect crossover study of single-dose PTC518 in healthy volunteers
NL-OMON51584Phase 1Completed
- Sponsor
- PTC Therapeutics, Inc.
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of votoplam in Huntington disease (HD) (2 arms), sponsored by PTC Therapeutics, Inc. Started Apr 2022; status: completed.
02
Drugs
votoplam
03
Conditions
Huntington disease (HD)
Beyond the preview
Go deeper on NL-OMON51584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51584.